Since tumor-infiltrating T cells, in particular CD8-positive T cells, play an important role for initiating and mediating a response to ICI, the in vivo visualization of CD8-positive T-cell-rich tissue might be crucial for development of more effective ICI therapies. Here, CD8A is linked to neoplasm.